A proposed rule that would expand the use of prior authorization and step therapy for Part D and Medicare Advantage beneficiaries has earned criticism from patient advocacy groups and praise from pharmacy groups.
A recent study in the Journal of the American Medical Informatics Association found that using population health data could help identify patients with a high risk of developing cardiovascular disease who have not been previously identified as high risk due to lack of relevant cholesterol data.
The opioid crisis in the U.S. continues to touch on issues of patient rights and privacy. In October, OCR launched an education campaign about civil rights protections that include specific guidelines for covered entities under HIPAA
Q: If a patient participating in a clinical trial is allergic to one of the drugs used in the trial, how do we report the drug that is used as a substitute?
A proposal to change discharge planning regulations has gotten new life. CMS announced last month that it is giving itself another year to publish the final version of the discharge planning rule.
